This is fucking depressing. I got my watchlist out and swinging low and no balls to execute a trade. The risk appetite in this market blows and nothing is lining up for me. QLYS is smoking shorts, EZ Wide style, fast and hot, which bodes well for my CYBR. But it’s barely up a buck. Give me a fucking break.
I have a few biotech names that I want to own too. But that problem with that is the asinine valuations of pre-revenue ventures, coupled with the mood of the market right now. If I am not careful, I am liable to get my fucking head blow clean off.
The only safe thing for me to do is to chill out and drink barrels of coffee, while the market dicks all of you. I can simply bide my time, if you will, and attempt to purchase one of your famous margin liquidations, which is always a treat. No?
Please do not contact me via email or Twitter. Also, if you’re coming to the 2nd Annual iBankCoin Investors Conference, or the VIP after-party, DO NOT try to figure out who I am. I will have eyes and ears everywhere. People have been killed for less.
For now, biotech and banks are leading the way to, umm, fucking nowhere. But they’re strong and virile.
If you enjoy the content at iBankCoin, please follow us on Twitter
Best Biotech hand grenade?
Once
I have an idea: physical gold bars and a very nice safe
no,…. not yet,…
wait for it,……..
$900-1000,
then go balls deep
Gold will go below 1000. Probably mid 900. Mines to shut and miners bankers. I love EDV. Lowest cost at around 900 around but tonnes of debt. 500000 ounce a year They will drop to mid 30s.
WTH Netflix.
FLY if I may Sir recommend FEYE as a core position. I know this one may leave a bad taste in your mouth but I believe this security firm is the real deal and will be number 1 soon enough. So now would be a good time buy? Any thought would be appreciated.
The issue with Feye is lack of profits
From a numbers perspective, there was very little not to like from the quarter.
•Revenue and billings were up 56% and 57%, respectively — both above guidance.
?International revenue was up 65%.
?There are now nine product lines with over $10 million in quarterly sales.
•Average contract length was 31 months, up from 29 months a year ago.
•FireEye signed 297 new customers and now has over 3,700 customers in 70 countries. Over half of FireEye customers now use more than one product from the company, increasing the stickiness of the relationship.
?The number of FireEye-as-a-service customers is up tenfold over the past year.
?FireEye now counts over 70 governments as customers.
•Cash from operations was a positive $39 million, versus -$62 million in the same period a year ago. Management is so encouraged by the momentum in the business that it now expects cash flow from operations to break even this year, more than two years ahead of expectations.
•Cash on the balance sheet stands at $1.2 billion, giving the company plenty of flexibility to grow as management sees fit.
A A P L-uLLLLLLLLLLLLLL
Yes- my short at 132 is looking good. Next stop 105, then 95, and pretty soon 60.